Stimulants augmentation with an antidepressant for the treatment of the major depressive disorder (MDD) | Zendy

Muath F. Marashdeh | Zendy; Eva Haddad | Zendy; Maxim A. Obaisat | Zendy; Malik M. Al-Alwan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Stimulants augmentation with an antidepressant for the treatment of the major depressive disorder (MDD)

Author(s) -

Muath F. Marashdeh,

Eva Haddad,

Maxim A. Obaisat,

Malik M. Al-Alwan

Publication year - 2019

Publication title -

international journal of scientific research and management (ijsrm)

Language(s) - English

Resource type - Journals

ISSN - 2321-3418

DOI - 10.18535/ijsrm/v7i4.mp02

Subject(s) - major depressive disorder , antidepressant , psychiatry , sedative , depression (economics) , medicine , convulsion , depressive symptoms , psychology , epilepsy , anxiety , cognition , economics , macroeconomics

The use of antidepressants and sedative drugs is the best treatment proved for major depressive disorder and in some cases the electrical convulsion therapy. The use of stimulants off-label in clinical practice an increasing concern as there is no research evidence to support their effectiveness.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research